Qube Research & Technologies (QRT)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.94M Buy
4,100
+500
+14% +$252K ﹤0.01% 2193
2025
Q4
$1.68M Sell
3,600
-400
-10% -$186K ﹤0.01% 2331
2025
Q3
$1.7M Sell
4,000
-100
-2% -$38.8K ﹤0.01% 2304
2025
Q2
$1.57M Buy
4,100
+3,800
+1,267% +$1.37M ﹤0.01% 2293
2025
Q1
$104K Sell
300
-1,500
-83% -$482K ﹤0.01% 3002
2024
Q4
$540K Buy
1,800
+1,400
+350% +$489K ﹤0.01% 2436
2024
Q3
$163K Buy
+400
New +$146K ﹤0.01% 2647
2024
Q1
Sell
-2,700
Closed -$731K 4639
2023
Q4
$731K Sell
2,700
-22,200
-89% -$5.49M ﹤0.01% 2095
2023
Q3
$6.12M Buy
24,900
+24,500
+6,125% +$6.7M 0.02% 846
2023
Q2
$121K Buy
+400
New +$111K ﹤0.01% 1913

Other funds holding HCA

Qube Research & Technologies (QRT)'s HCA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its HCA Healthcare (HCA) stake by 9.2% in Q1 2026, selling an estimated $9.39M and leaving 183,870 shares worth $87M. The position accounts for 0.1% of the portfolio, ranked #249.

Qube Research & Technologies (QRT) first reported a position in HCA in Q2 2018 and has held it in 24 quarters since. The position peaked at $310M in Q4 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 183,870 shares of HCA Healthcare worth $87M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 18,655 HCA Healthcare shares in Q1 2026, an estimated $9.39M.
  • HCA Healthcare made up 0.1% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #249 holding.
  • Qube Research & Technologies (QRT) first reported a position in HCA Healthcare in Q2 2018 and has held it in 24 quarters since.
  • Qube Research & Technologies (QRT)'s HCA Healthcare position peaked at $310M in Q4 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.